DFFVX
Price
$33.73
Change
-$0.08 (-0.24%)
Updated
Aug 6 closing price
Net Assets
12.88B
RSVIX
Price
$14.34
Change
-$0.14 (-0.97%)
Updated
Aug 6 closing price
Net Assets
4.26M
Interact to see
Advertisement

DFFVX vs RSVIX

Header iconDFFVX vs RSVIX Comparison
Open Charts DFFVX vs RSVIXBanner chart's image
DFA US Targeted Value I
Price$33.73
Change-$0.08 (-0.24%)
VolumeN/A
Net Assets12.88B
RBC Small Cap Value I
Price$14.34
Change-$0.14 (-0.97%)
VolumeN/A
Net Assets4.26M
DFFVX vs RSVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DFFVX vs. RSVIX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFFVX is a Buy and RSVIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFFVX has more cash in the bank: 12.9B vs. RSVIX (4.27M). DFFVX pays higher dividends than RSVIX: DFFVX (1.62) vs RSVIX (1.07). DFFVX was incepted earlier than RSVIX: DFFVX (25 years) vs RSVIX (11 years). RSVIX (1.37) is less costly to investors than DFFVX (0.30). RSVIX is a more actively managed with annual turnover of: 56.00 vs. DFFVX (7.00). DFFVX has a lower initial minimum investment than RSVIX: DFFVX (0) vs RSVIX (100000). DFFVX annual gain was more profitable for investors over the last year : 7.72 vs. RSVIX (-1.84). DFFVX return over 5 years is better than : 88.91 vs. RSVIX (47.25).
DFFVXRSVIXDFFVX / RSVIX
Total Expense Ratio0.290.8634%
Annual Report Gross Expense Ratio0.301.3722%
Fund Existence25 years11 years-
Gain YTD-0.958-6.58115%
Front LoadN/AN/A-
Min. Initial Investment0100000-
Min. Initial Investment IRAN/AN/A-
Net Assets12.9B4.27M302,462%
Annual Yield % from dividends1.621.07151%
Returns for 1 year7.72-1.84-419%
Returns for 3 years23.0613.77167%
Returns for 5 years88.9147.25188%
Returns for 10 years62.6857.70109%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EQ0.640.04
+6.96%
Equillium
ALHC13.710.30
+2.24%
Alignment Healthcare
KVAC11.45N/A
N/A
Keen Vision Acquisition Corp
CTVA71.17-1.14
-1.58%
Corteva
TLX11.97-0.29
-2.37%
Telix Pharmaceuticals Ltd.